Afuco™ Anti-αVβ3 Integrin ADCC Therapeutic Antibody (Etaracizumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized (from mouse) antibody expressed in CHO binding to human αVβ3 integrin. Etaracizumab is a humanized monoclonal antibody which is being investigated for the treatment of metastatic melanoma, prostate cancer, ovarian cancer and various other types of cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-705 |
| Pricing | Inquiry |
| Host | Human |
| Target | αVβ3 Integrin |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | FC, IP, ELISA, Neut, FuncS, IF |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |